AJP - Renal Physiology, Vol 252, Issue 5 829-F837, Copyright © 1987 by American Physiological Society

ARTICLES

Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons

K. A. Nath, D. H. Chmielewski and T. H. Hostetter

The glomerular microcirculation of the remnant nephron is characterized by reduced afferent (RA) and efferent (RE) arteriolar resistances and markedly increased single nephron glomerular plasma flow and filtration rates. We investigated the role of prostanoid production in mediating these adaptive alterations in glomerular hemodynamics after the reduction of renal mass. Acute administration of indomethacin, 5 mg/kg iv in anesthetized euvolemic, Sprague-Dawley rats with intact kidneys led to no significant alteration in renal hemodynamics, whereas in similarly prepared subtotally nephrectomized rats such inhibition significantly reduced remnant kidney glomerular filtration rate from 0.57 +/- 0.07 to 0.45 +/- 0.05 ml/min and single nephron glomerular filtration rate (SNGFR) from 93 +/- 4 to 72 +/- 5 nl/min. This reduction in SNGFR was due to diminutions in the glomerular ultrafiltration coefficient (Kf) from basal values of 0.061 +/- 0.004 to 0.050 +/- 0.004 nl X s-1 X mmHg-1 and in initial glomerular capillary plasma flow rate (QA) from 416 +/- 42 to 321 +/- 42 nl/min. The decrease in QA was a consequence of proportional increases in RA and RE. In other groups of animals we demonstrated that urinary excretions of both vasodilatory as well as vasoconstrictor prostanoids per surviving nephron increase several fold in subtotally nephrectomized rats compared with rats with intact kidneys and that administration of indomethacin, 5 mg/kg iv, reduced urinary excretions of both vasodilatory prostaglandins, prostaglandin E and 6-keto-prostaglandin F1 alpha, as well as vasoconstrictor prostanoid, thromboxane B2, to the same degrees in both subtotally nephrectomized rats and rats with intact kidneys.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954. [Abstract] [Full Text] [PDF]

				R. C. HARRIS Cyclooxygenase-2 in the Kidney J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2387 - 2394. [Full Text]

				P. L. Sanchez, L. M. Salgado, N. R. Ferreri, and B. Escalante Effect of Cyclooxygenase-2 Inhibition on Renal Function After Renal Ablation Hypertension, October 1, 1999; 34(4): 848 - 853. [Abstract] [Full Text] [PDF]

				S. A. Brown, D. R. Finco, and C. A. Brown Is There a Role for Dietary Polyunsaturated Fatty Acid Supplementation in Canine Renal Disease? J. Nutr., December 1, 1998; 128(12): 2765S - 2765. [Abstract] [Full Text]

				J.-L. Wang, H.-F. Cheng, M.-Z. Zhang, James. A. McKanna, and R. C. Harris Selective increase of cyclooxygenase-2 expression in a model of renal ablation Am J Physiol Renal Physiol, October 1, 1998; 275(4): F613 - F622. [Abstract] [Full Text] [PDF]

				C. K. Fujihara, D. M. A. C. Malheiros, J. L. Donato, A. Poli, G. De Nucci, and R. Zatz Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney Am J Physiol Renal Physiol, March 1, 1998; 274(3): F573 - F579. [Abstract] [Full Text] [PDF]

				J. Hernandez, H. Astudillo, and B. Escalante Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure Am J Physiol Renal Physiol, April 1, 2002; 282(4): F592 - F598. [Abstract] [Full Text] [PDF]